BioSpace News Archive

Business

Neuromod appoints Teri Minard to lead introduction of tinnitus treatment medical device to US Veterans

Neuromod Devices Ltd, the medical device company which specialises in neuromodulation technologies, has announced the appointment of Ms. Teri Minard as Director, Government Sales of its recently established US entity, Neuromod USA Inc.

October 27, 2021
·
6 min read
Aston Sci. Announces the Study Results of Two Therapeutic Cancer Vaccines at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Aston Sci., a portfolio model biopharmaceutical company, announced that the study results of its therapeutic cancer vaccine pipelines, AST-301 and AST-021p, will be presented at the Society for Immunotherapy of Cancer(SITC) in November.

October 27, 2021
·
2 min read
Satellos Bioscience Inc. Retains BND Projects Inc. for Strategic Investor Relations Services

BND will aid the Corporation in building awareness in the financial community by introducing, maintaining and protecting relationships between the management of the Corporation and professional investors.

October 27, 2021
·
5 min read
Entheon Biomedical Provides Corporate Update on Studies and Clinical Trials

Entheon is pleased to announce that its observational study assessing the neurophysiological effects of ketamine is progressing as planned.

October 27, 2021
·
6 min read
Drug Development

NervGen Pharma Announces Spinal Cord Injury Clinical Advisory Board

This Clinical Advisory Board will work closely with NervGen as the Company prepares for its upcoming Phase 1b/2 clinical trial for spinal cord injury with its lead compound, NVG-291.

October 27, 2021
·
12 min read
Launch of Seegene’s STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

South Korea’s leading molecular diagnostics (MDx) developer Seegene Inc., (KQ 096530) is addressing the needs of small, mid-sized, and large hospitals and COVID-19 laboratories with its fully automated STARlet-AIOS: All-in-One System (AIOS).

October 27, 2021
·
3 min read
Pharm Country

New Report Will Help the FDA to Evaluate Future Treatments for Frontotemporal Degeneration

Today, The Association for Frontotemporal Degeneration (AFTD) released Frontotemporal Degeneration (FTD): A Voice of the Patient Report.

October 27, 2021
·
3 min read
Lone Star Bio

Plus Therapeutics Announces Presentation of ReSPECT-GBM Trial Dosimetery Data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today presented data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting.

October 27, 2021
·
7 min read
Drug Development

Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today positive preliminary results from two Phase 2 studies designed to identify the hospitalized patient population suffering from COVID-19-induced pneumonia and respiratory depression likely to respond to treatment with oral Abivertinib.

October 27, 2021
·
9 min read
Business

SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021

SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open on Wednesday, November 10, 2021.

October 27, 2021
·
1 min read